Sunday 29 March 2020 ,
Latest News
No new coronavirus case reported in 24 hrs in Bangladesh:IEDCR | Rumors hampering fight against coronavirus in South Asia | Coronavirus crisis: Global death toll now 27,359 | 5 killed in Tangail road crash | Trump signs $2 trillion recovery plan as US virus cases skyrocket | Mobile court’s punishment in Monirampur sparks huge | Coronavirus cases rise to 48 in Bangladesh | The new hot line number for coronavirus: 01944333222 |
31 July, 2019 08:46:11 AM

Print

Beximco Pharma starts export of 5th product to US

STAFF REPORTER, Dhaka
Beximco Pharma starts export of 5th product to US

The country’s leading medicine exporter Beximco Pharmaceuticals Limited has commenced export of a blood pressure drug, Nadolol, to the US market.

Nadolol tablets (20mg, 40mg and 80mg) are the generic equivalent of Bristol-Myers Squibb’s Corgard tablets for treating hypertension and angina pectoris (chest pain).

This is Beximco’s fifth product to the US market following the successful launching of Carvedilol, Sotalol, Methocarbamol and Metformin.  According to IQVIA audited data of US market, the total market for Nadolol was more than $63 million in 2018, a press statement said.

Nazmul Hassan, managing director of Beximco Pharmaceuticals, said, “We are delighted to announce the launch of Nadolol, our fifth product in the US market, which demonstrates continued progress in expanding our presence in this important market.”

“With a strong portfolio and an attractive pipeline of products in development for the US and other regulated and emerging markets, we are well positioned to continue to achieve double-digit growth in our export business,” he said.

In August 2016, Beximco Pharma became the first Bangladeshi pharmaceutical company to export medicine to the US market following its manufacturing site approval by the US FDA in June 2015, the statement said.   

BK

.

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 47.3%
No 48.7%
No Comment 4.1%
Video
More Business Stories

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting